Content validity of a newly developed observer-reported measure for pediatric asthma in children aged 2-5 years
- PMID: 35633412
- PMCID: PMC9148329
- DOI: 10.1186/s41687-022-00461-y
Content validity of a newly developed observer-reported measure for pediatric asthma in children aged 2-5 years
Abstract
Background: An observer-reported outcome (ObsRO) measure assessing both symptom control and health-related quality of life (HRQoL) in children with asthma younger than 6 years is lacking. The objective of this study was to evaluate the content validity of the Pediatric Asthma Questionnaire (PAQ), a newly developed 6-item ObsRO measure for caregivers of children aged 2-5 years diagnosed with asthma.
Results: In-depth, qualitative interviews were conducted with 15 parents or caregivers. The first part of the interview was an open-ended discussion whereby participants were asked to describe their observations of their child's asthma symptoms and HRQoL impacts followed by a cognitive debriefing of a draft version of the PAQ. The most frequently reported symptoms were coughing (n = 15, 100%), wheezing (n = 14, 93%), and trouble breathing (n = 10, 67%). Overall, participants found the PAQ easy to complete and relevant to their child's experience with asthma, with most reporting the instructions, response scales, and recall period for the items to be appropriate. The majority of participants (93%) believed they could accurately report on the items included in the PAQ based on their observations of their child's asthma symptoms and impacts, or reliably get the information from the child's teacher, school, or caregiver when their child was not in their presence. One item was modified based on feedback about the phrase "oral steroids" to clarify modes of administration. A few other minor changes were incorporated into the PAQ following suggestions from participants, including replacing the phrase "how often" with "how many days" in one of the items to improve clarity and overall consistency with the response options.
Conclusion: Qualitative data support the content validity of the PAQ as a fit-for-purpose and well-understood 6-item observer-reported outcome measure to evaluate both symptoms and asthma-specific HRQoL impacts experienced by pediatric asthma patients aged 2-5 years for use in clinical and real-world studies.
Keywords: Asthma; Content validity; HRQoL; Health-related quality of life; ObsRO; Observer-reported outcome; PAQ; PRO; Patient-reported outcome; Pediatric; Pediatric Asthma Questionnaire.
© 2022. The Author(s).
Conflict of interest statement
JC, SK, and YZ are employees of Regeneron Pharmaceuticals, Inc. AHK is an employee of Sanofi, France. JC, SK, SM, and TS are employees of Clinical Outcomes Solutions, who designed and undertook this research. RK declares no competing interests.
Similar articles
-
Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).J Patient Rep Outcomes. 2023 Oct 20;7(1):104. doi: 10.1186/s41687-023-00639-y. J Patient Rep Outcomes. 2023. PMID: 37863864 Free PMC article.
-
Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.Adv Ther. 2022 Nov;39(11):5126-5143. doi: 10.1007/s12325-022-02261-8. Epub 2022 Sep 6. Adv Ther. 2022. PMID: 36066744 Free PMC article. Review.
-
Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures.J Patient Rep Outcomes. 2023 Jul 19;7(1):74. doi: 10.1186/s41687-023-00610-x. J Patient Rep Outcomes. 2023. PMID: 37466759 Free PMC article.
-
The Amblyopia Quality of Life (AmbQoL): Development and Content Validation of a Novel Health-Related Quality of Life Instrument for Use in Adult and Pediatric Amblyopia Populations.Ophthalmol Ther. 2023 Apr;12(2):1281-1313. doi: 10.1007/s40123-023-00668-2. Epub 2023 Feb 24. Ophthalmol Ther. 2023. PMID: 36828953 Free PMC article.
-
Development of an observer-reported outcome measure to capture the signs and impact of fever distress symptoms in infants and young children.Qual Life Res. 2022 May;31(5):1573-1585. doi: 10.1007/s11136-021-03049-z. Epub 2022 Jan 7. Qual Life Res. 2022. PMID: 34993744 Review.
Cited by
-
Development of a novel patient-reported outcome measure for disseminated coccidioidomycosis (valley fever).J Antimicrob Chemother. 2025 Mar 3;80(3):657-665. doi: 10.1093/jac/dkae453. J Antimicrob Chemother. 2025. PMID: 39688396 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Most recent national asthma data. Available at: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm. Accessed 2 Nov 2020
Grants and funding
LinkOut - more resources
Full Text Sources